Related Experiment Videos
Radiolabeled monoclonal antibodies
1Baylor University Medical Center, Dallas, USA.
Abstract:
Monoclonal antibodies (MoAbs) are biologically engineered proteins designed to bind to antigens emanating from tumor cells. Selected radioactive isotopes are fused with MoAbs to allow radioimmunodetection of external imaging of metastatic deposits in patients with colon cancer. For the past 10 years, radiolabeled MoAbs have improved tumor localization techniques and influenced the clinical management of surgical patients. Intraoperatively, surgeons use appropriately shielded, handheld, gamma detection probes to locate radiolabeled MoAbs and corresponding colon cancers (ie, residual, recurrent tumors). Using gamma detection probes intraoperatively, surgeons can localize nonpalpable occult tumors and disease not suspected from external antibody scans or other traditional diagnostic methods. This success confirms the need for complete tumor resections, thorough scanning of entire tumor beds, and ex vivo scanning of surgical specimens to assess for potential nodal metastases.
Insights
Radiolabeled monoclonal antibodies (MoAbs) improve colon cancer detection during surgery. Surgeons use gamma probes to find occult tumors missed by other methods, enhancing resection accuracy.
Area of Science:
- Oncology
- Immunology
- Nuclear Medicine
Background:
- Monoclonal antibodies (MoAbs) are engineered proteins targeting tumor antigens.
- Radioactive isotopes fused with MoAbs enable radioimmunodetection for imaging.
- Radiolabeled MoAbs have been used for a decade in colon cancer management.
Observation:
- Intraoperative gamma detection probes locate radiolabeled MoAbs and colon cancers.
- These probes identify nonpalpable, occult tumors and unsuspected disease.
- This technique aids in detecting residual or recurrent tumors.
Findings:
- Radiolabeled MoAbs significantly enhance intraoperative tumor localization.
- Gamma probe use improves the detection of metastatic deposits.
- The method is effective for identifying disease not found by external scans.
Implications:
- Confirms the necessity of complete tumor resections.
- Supports thorough scanning of tumor beds and ex vivo specimen analysis.
- Improves surgical management and assessment of nodal metastases in colon cancer patients.